CBRS CBRS
Company Profile ↓Company Overview
CBRS (CBRS) is a publicly traded company listed on with a market capitalization of $46.10B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 77.9% per year over the last five years.
Revenue has grown at a 174.6% CAGR over the past five years.
Maintains a net profit margin of 46.6%.
Recent Developments
- Dec 2025 Revenue of $509.99M (+75.7% YoY); net profit $237.83M.
- Trailing 12 Months Year-on-year growth — revenue +75.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 174.6%, profit CAGR 77.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 174.64% |
| 1 Year: | 75.71% |
Compounded Profit Growth
| 5 Years: | 77.94% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -31.11% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | +21.34% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- RSI (14)50.74 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 46.6%.
- Compounding revenue at 174.6% over 5 years.
- Profit CAGR of 77.9% over 5 years.
CONS
- Trading at a high P/E of 510.2.
- Trading 31.1% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue | 99.51M | 193.41M |
| Cost of Revenue | 57.91M | 107.23M |
| Gross Profit | 41.60M | 86.18M |
| Operating Expenses | 70.28M | 102.47M |
| Operating Income | -28.68M | -16.29M |
| EBITDA | -18.27M | 24.61M |
| Interest Expense | 0 | 18.95M |
| Pretax Income | -22.18M | -12.51M |
| Tax Provision | 1.68M | 1.50M |
| Net Income | -23.87M | -14.01M |
| Diluted EPS | -0.13 | -0.07 |
| R&D Expense | 52.75M | 75.50M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 24.62M | 78.74M | 290.25M | 509.99M |
| Cost of Revenue | 21.73M | 52.39M | 167.51M | 310.92M |
| Gross Profit | 2.89M | 26.36M | 122.74M | 199.07M |
| Operating Expenses | 181.71M | 160.29M | 224.38M | 344.32M |
| Operating Income | -178.82M | -133.93M | -101.64M | -145.25M |
| EBITDA | -166.88M | -123.35M | -90.10M | -110.80M |
| Interest Expense | - | - | - | - |
| Pretax Income | -177.51M | -127.02M | -479.68M | 244.88M |
| Tax Provision | 204.00K | 132.00K | 1.93M | 7.06M |
| Net Income | -177.72M | -127.16M | -481.60M | 237.83M |
| Diluted EPS | -0.98 | -0.70 | -2.68 | 0.42 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | 281.49M | 225.50M | 1.11B | 2.33B |
| Current Assets | 253.17M | 212.29M | 1.03B | 1.54B |
| Cash & Equivalents | 26.08M | 34.76M | 220.21M | 701.71M |
| Inventory | 19.54M | 49.08M | 174.49M | 63.63M |
| Receivables | 3.73M | 6.76M | 137.44M | 50.42M |
| Total Liabilities | 747.83M | 784.46M | 2.08B | 2.90B |
| Current Liabilities | 21.80M | 54.64M | 1.18B | 719.54M |
| Long Term Debt | - | - | - | - |
| Total Debt | 1.30M | 560.00K | 40.67M | 261.82M |
| Total Equity | -466.33M | -558.96M | -966.79M | -578.65M |
| Shares Outstanding | 215.11M | 215.11M | 215.11M | 215.11M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -164.40M | -78.98M | 451.98M | -10.05M |
| Investing Cash Flow | 137.39M | 81.70M | -16.79M | -667.58M |
| Financing Cash Flow | 9.10M | 5.93M | 112.30M | 1.03B |
| Capital Expenditure | -10.46M | -6.59M | -23.43M | -382.74M |
| Free Cash Flow | -174.87M | -85.57M | 428.54M | -392.79M |
| Net Change in Cash | -17.91M | 8.66M | 547.49M | 348.93M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | 11.7% | 33.5% | 42.3% | 39.0% |
| Operating Margin % | -726.4% | -170.1% | -35.0% | -28.5% |
| Net Margin % | -721.9% | -161.5% | -165.9% | 46.6% |
| ROE % | 38.1% | 22.7% | 49.8% | -41.1% |
| ROCE % | -68.9% | -78.4% | 155.4% | -9.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CBRS
CBRS Dips In Premarket: CEO Reportedly Says Working With All AI Component Makers Except Nvidia - Stocktwits
<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxQRW1TdEcwV1BHVkFNd0t6U2RGRnZRdWNob0otRlJySnVIN2FIeVBxWWozTUJOZzhrbDVMVUlOSkEzbDhER0pwN0piVUZERmJtQld0emdnVTRpLW9NZE1zV3YtdjhzSlJtbkVQQ1ZuNnpCLUZsRUJVeGtyM0xQMGRCSFQ3VHZSUTVyRlQ1R1…
Lovable Users Behind More Than 50M Projects Could Get Faster AI Responses - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxOdkxJOExCUzJPYjYzZy1TRFJReFc3Y3VzYVRRUHZQS3B6TERNWk5LQ0RxV2wxQTN0dUNrMnEzVWxMeGlEZkQ0Nkl5NHZtOTdqT3lOVThmckNqdTE5VUFTMEZhc0hWUUF1MXYzVUNIb3dZV0NoUlpqM1l1aXBlelpUZ19Qemgyd0phdVEzeH…
Why is Cerebras Systems stock surging today? - Investing.com
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPdkxid2VaX3l6Zm5hWGNJSm9SN001Y19LLU9TVE5NU1Z4WGZSN0xGMXlxNm1sNGpVZDA4NEhWWTVjTjlVdFp6czRreDJlV0Vnd0tkbFVpUDZfZ1NvV0dTU1NYOEVZaW1ORzlDeDhpMlVsWThockpoUlZBeUlQaGtLM3pMSmNFY2J4bVMwck…
CBRS vs. AVGO: Which Stock Leads the AI Infrastructure Boom? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQT2FSTnd4SUUxbEdmeG56U1VqMVFlOXJzamJvUDFjb3o0Q3ZiWU9KSW9pR1ZnRGVlNjlvbl9nXzJlSFhCallqRGJCRlQ2dFo0NXVBTlR0YV9JVkxmb05ES3ZqYnJRQkl2UDZtWkI1V0xZdk5CSUVZSHR0OWJNbGdUYmVTQklIMUVHNExrTU…
$CBRS stock is up 4% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxPSW5mdS04M1g3Z1VmYWdPbWVNamtnZTc0WlA1OF9DRHFnN2JzV1k0YnBIbWMyenpTc2wzcnU2UlRETWliVjFVYjVORGtuWXh4c3JubEVfWnE2QXdSR0k3eDVnVVFfNm5ndmJFU0RoWDFaczgyZlh5MUhTOGZ2MnN4R1diaHUzTUVIX055am…
Cathie Wood Bought Cerebras Systems Stock the Same Week the AI Chip Startup's Shares Fell More Than 58% From Their First-Day IPO Pop - The Motley Fool
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxNbk9ZMjdlTDFYektCei1LY3hNUXFfUGw0M1lZVWI3UXB3ZEM5X2lvbHNWN3lfZ2h3bHRUekdUWE5ENnd0azZTQllwQWhQT0tEV3lEVDVUUmJCLVBMUUJ6SlNBUFJVLU9kOWFvb0VoWDBTcWYwNGRidURmUTJQUzV6SExiRnh1WlhNUFlzVk…
CBRS — Frequently Asked Questions
What is the current share price of CBRS?
As of 2026-08-05 17:25 PDT, CBRS trades at $214.30 on NASDAQ/NYSE. Its 52-week range is $168.52 to $311.07.
What is the market capitalisation of CBRS?
CBRS has a market capitalisation of $46.10B on NASDAQ/NYSE.
What is the P/E ratio of CBRS?
CBRS trades at a trailing price-to-earnings (P/E) ratio of 510.24. Its price-to-book (P/B) ratio is -79.67.
What is the return on equity (ROE) of CBRS?
CBRS has a return on equity (ROE) of -41.10%. Its return on capital employed (ROCE) is -9.04%.
Is CBRS a good stock to buy?
This page provides a data-driven analysis of CBRS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.